AMR International supported the transaction with buy-side Commercial Due Diligence (CDD).
AMR supported Elsevier and RELX in evaluating the adoption curves of 3D anatomy tools across customer segments and regions. In addition, we evaluated the commercial landscape of 3D anatomy vendors serving the market.
As well as assessing the base business plan, AMR also tested and quantified the revenue potential of combining 3D anatomy tools with Elsevier’s world leading anatomy education and content.
See Elsevier media release for more details.
For further information please contact one of AMR’s Private Equity Team: